#Canada #Toronto #Clinical Trials #Xtalks #IMP labeling

Join the Webinar on Centralized IMP Labeling Workflows

In an ever-evolving pharmaceutical landscape, ensuring that clinical trials run smoothly is essential for the success of new drugs. One significant area that can impact the efficiency of these trials is the labeling of Investigational Medicinal Products (IMP). Centralized IMP labeling workflows offer a solution to reduce risks associated with relabeling and avoid startup delays.

What to Expect from the Webinar

Xtalks presents an informative and free webinar that will delve into the intricacies of centralized IMP labeling workflows. This event promises insights from industry experts on how standardizing and streamlining the labeling process can enhance compliance and operational efficiency. Participants will learn how to manage the full labeling pathway effectively— from the initial creation of label text to its translation and final distribution.

Featured Speakers

The webinar features prominent figures in clinical trial supplies, including:

• - Amalie Engemand Henriksen, Director at Genmab A/S
• - Sandeep Anne, Senior Director at Jazz Pharmaceuticals
• - James Bardsley, Independent Consultant
• - Alyssa Ogunnowo, Director at TransPerfect Life Sciences, will act as the moderator.

Key Topics Covered

One of the focal points will be the establishment of practical operating models designed to foster greater visibility and accountability within the labeling process. Important discussion points include:

• - Developing a “single source of truth” for label text to minimize discrepancies
• - Standardizing templates and phrasing libraries for enhanced clarity across teams
• - Clearly defining review and approval roles to streamline processes
• - Building timelines that reflect country-specific requirements for compliance

Benefits of Centralized Workflows

Centralized workflows not only speed up the process of getting a drug to trial but also ensure adherence to regulatory standards. With a focus on multilingual labeling, this strategy addresses potential pitfalls that often lead to costly delays.

The webinar will share real-life examples of how organizations have successfully implemented centralized workflows, highlighting common pitfalls and proven controls. By tracking performance indicators and ensuring audit-ready documentation, participants will learn how to reduce errors and avoid the last-minute firefighting often seen in clinical trials.

Why You Should Attend

This is an excellent opportunity for professionals across pharmaceutical organizations who are involved in clinical operations, regulatory affairs, and quality assurance to fortify their understanding and approach to IMP labeling. Attending the webinar will help organizations enhance their compliance measures and streamline their processes, thereby positioning them favorably in the competitive pharmaceutical market.

When and How to Join

Mark your calendars for June 08, 2026, at 11 AM EDT (5 PM CEST) for this live session. To register or learn more about the webinar, visit the Xtalks website and enhance your knowledge about effective labeling processes that can transform clinical trials.

Conclusion

As the pharmaceutical industry continues to advance, understanding and optimizing IMP labeling workflows becomes increasingly crucial. Join us in exploring how centralized strategies can reduce labeling risks and expedite study start-ups, ensuring that new treatments reach those in need without unnecessary delay.